Meloxicam 15 mg Tablets Under Fasting Conditions

NCT00840476 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Teva Pharmaceuticals USA